Perspectives of breast cancer thermotherapies

Journal of Cancer

Volumn 5, Issue 6, 2014, Pages 472-479

  Alphandéry, Edouard ^a,b  

^a Nanobacterie SARL   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

Breast cancer; Thermotherapies

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IFOSFAMIDE; NANOPARTICLE; PROGESTERONE; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CRYOTHERAPY; ECHOGRAPHY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; INFRARED RADIATION; LASER THERMOTHERAPY; LIVER TUMOR; LOCAL METASTASIS; MAGNETIC FIELD; MAGNETIC HYPERTHERMIA; MAGNETOSOME; MAMMOGRAPHY; MASTECTOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; REVIEW; THERAPY EFFECT; TUMOR VOLUME;

EID: 84902467268     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.8693     Document Type: Review

References (78)

1. General information about breast cancer. www.breastcancer.org, www.nationalbreastcancer.org, www.cancer.gov/cancertopics/types/breast, www.breastcancercare.org.uk.
2. Cindy B, Matsen MD, Leigh A, et al. Breast Cancer: A Review for the General Surgeon. JAMA 2013; 148: 971-980.
3. Tinoco G, Warsch S, Gluck S, et al. Treating Breast Cancer in the 21st Centrury: Emerging Biological Therapies. J Cancer 2013; 4: 117-132.
4. [Internet] Document published on the website of the centers for Disease Control and Prevention. http: //www.cdc.gov/nchs/data/hus/hus12.pdf.
5. Zackrisson S, Andersson I, Janzon L, et al. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006; 332: 689-693.
6. [Internet] Document describing the intrabeam therapy. http: //www.meditec.zeiss.com/intrabeam.
7. [Internet] Website of the mammosite company. http: //www.mammosite.com.
8. Kapp DS, Barnett TA, Cox RS, et al. Hyperthermia and radiation therapy of local-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors. Int. J. Radiat. Oncol. Biol. Phys. 2008, 20: 1147-64.
9. Higgins MJ, and Baselga J. Targeted therapies for breast cancer. The J. Clin. Investigation 2011, 121: 3797-3803.
10. Nuti M, Bellati F, Visconti V, et al. Immune Effects of Trastuzumab. J Cancer 2011, 2: 317-323.
11. Two websites with information concerning clinical trials on BC. www.clinicaltrials.gov, www.breastcancertrials.org.
12. Hilderbrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Critical Reviews in Oncology/Hemathology 2002, 43: 33-56.
13. Chichel A, Skowronek J, Kubaszewska M, et al. Hyperthermia-description of a method and a review of clinical applications. Radiotherapy 2007, 12: 267-275.
14. Barnes JA, Dix DJ, Collins BW, et al. Expression of inducible HsP70 enhances the proliferation of MC-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress and Chaperones 2001, 6: 316-325.
15. Braiden V, Ohtsuru A, Kawashita Y, et al. Eradication of Breast Cancer Xenografted by Hyperthermic Suicide Gene Therapy under the Control of the Heat Shock Protein Promoter. Human Gene Therapy 2000, 11: 2453-2463.
16. Perez CA, Pajak T, Enami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superfical measurable tumors: final report by the Radiation Therapy Oncology Group. Am. J. Clin. Oncol. 1991, 14: 133-141.
17. Vernon C, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int. J. Oncol. Biol. Phys. 1996, 35: 731-744.
18. Chinel C, Skowronek J, Kubaszewska M, et al. Hyperthermia-description of a method and a review of clinical applications. Rep. Pract. Oncol. Radiother. 2007, 12: 267-275.
19. Kim JH, Hahn GM, Carlon RW. Combination hyperthermia and radiation therapy for malignant melanoma. Cancer 1982, 50: 478-482.
20. Gonzalez DG, Van Dijk JDP, Blank LECM. Chestwall recurrences of breast cancer: Results of combined treatment with radiation and hyperthermia. Radiology and Oncology 1988, 12: 95-103.
21. Linthorst M, Van Geel AN, Baaijens M, et al. Re-irradiation and hyperthermia after surgery for recurrent cancer. Radiotherapy and Oncology 2013; doi: 10.1016/j.radonc.2013.05.010.
22. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized Trial of Hyperthermia and Radiation for Superficial Tumors. J. clinical oncology 2005, 23: 3079-3085.
23. Vernon CC, Hand JWH, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int. J. Radiation Oncology 1996, 35: 731-744.
24. Zee J, Treurniet-Donker AD, The SK, et al. Low dose reirradiation in combination with hyperthermia: a palliative treatment for patients with breast cancer recurring in previously irradiated areas. Int. J. Radiation Oncology Biol. Phys. 1988, 15: 1407-1413.
25. Kapp DS, Barnett TA, Cox RS, et al. Hyperthermia and radiation therapy of loco-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors. Int. J. Radiation Oncology Biol. Phys. 1991, 20: 1147-1164.
26. Yokoyama G, Fujii T, Ogo E, et al. Advanced chemoresistant breast cancer responding to multidisciplinary treatment with hyperthermia, radiotherapy, and intraarterial infusion. Int. J. Clin. Oncol. 2005, 10: 139-143.
27. Zagar TM, Oleson JR, Vujaskovic Z, et al. Hyperthermia for locally advanced breast cancer. Int. J. Hyperthermia 2010, 26: 618-624.
28. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002, 3: 487-497.
29. [Internet] Identifier: NCT 00003135. http: //www.clinicaltrials.gov.
30. Kullberg M, Mann K, Owens JL. A two-component drug delivery system using HER-2 targeting thermosensitive liposomes. J. Drug Targeting 2009; 17: 98-107.
31. Yamamoto D, Inui T, Tsubota Y, et al. The utility of hyperthermia for local recurrence of breast cancer. World Journal of Surgical Oncology 2012, 10: 1-3.
32. Feyerabend T, Wiedemann GF, Jäger B, et al. Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease. Int. J. Radiation Oncology Biol. Phys. 2001, 49: 1317-1325.
33. Kouloulias VE, Dardoufas CE, Kouvaris JR, et al. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. Clin. Cancer Res. 2002, 8: 374-82.
34. Hachisuka J, Doi K, Furuea M. Combination cryosurgery with hyperthermia in the management of skin metastasis from breast cancer: A case report. Int. J. Surg. Case Rep. 2012, 3: 68-69.
35. Fornage BD, Snelge N, Ross MI, et al. Small (. Radiology 2004, 231: 215-224.
36. Hayashi A, Silver SF, Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. The American Journal of Surgery. 2003, 185: 429-435.
37. Oura S, Tamaki T, Hirai I, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 2007, 14: 48-54.
38. Abe H, Kurumi Y, Naka S, et al. Open-Configuration MR-Guided Microwave Thermocoagulation Therapy for Metastatic Liver Tumors from Breast Cancer. Breast Cancer 2005, 12: 26-31.
39. Sun Y, Zheng Y, Ran H, et al. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials 2012, 33: 5854-5864.
40. Wu F, Wang ZB, Cao Y-De, et al. A randomized clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localized breast cancer. British J Cancer 2003, 89: 2227-2233.
41. Huber PE, Jenne JW, Rastert R, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer research 2001, 61: 8441-8447.
42. Wu F, Wang ZB, Zhu H, et al. Extracorporal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Research and Treatment 2005, 92: 51-60.
43. Wu F, Wang ZB, Cao YDC, et al. "Wide local ablation" of localized breast cancer using high intensity focused ultrasound. J. Surgical Oncology 2007, 96: 130-136.
44. [Internet] Insightec. www.insightec.com.
45. Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc. Nanobiotechnol 2005, 152: 33-39.
46. Akimov AB, Seregin VE, Rusanov KV, et al. Nd: YAG interstitial laser thermotherapy in the treatment of breast cancer. Lasers in surgery and medicine 1998, 22: 257-267.
47. Milne PJ, Parel JM, Manns F, et al. Development of stereotactically guided laser interstitial thermotherapy of breast cancer: In situ measurement and analysis of the temperature field in ex vivo and in vivo adipose tissue. Lasers in surgery and medicine 2000, 26: 67-75.
48. Haraldsdóttir KH, Ivarsson K, Götberg S, et al. Interstitial laser thermotherapy (ILT) of breast cancer. Eur. J. Surg. Oncol. 2008, 34: 739-745.
49. Quesson B, Zwart JA, Moonen CTW. Magnetic resonance temperature imaging guidance of thermotherapy. J. Magn. Res. Imag. 2000, 12: 525-533.
50. Arthur RM, Straube WL, Trobaugh JW, Moros EG. Non-invasive estimation of hyperthermia temperatures with ultrasound. Int. J. Hyperthermia 2005, 21: 589-600.
51. DeNardo SJ, DeNardo G, Miers LA, et al. Development of Tumor Targeting Bioprobes (111In-Chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin. Canccer Res. 2005, 11: 7087s-7092s.
52. DeNardo SJ, DeNardo GL, Natarajan A, et al. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. The J Nuclear Medicine 2007, 48: 437-444.
53. Kikumori T, Kobayashi T, Sawaki M, et al. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res. Treat. 2009, 113: 435-441.
54. Mi Y, Liu X, Zhao J, et al. Multimodality treatment of cancer with herceptin conjugated thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials 2012, 33: 7519-7529.
55. Zhang J, Dewilde AH, Chinn P, et al. Herceptin-directed nanoparticles activated by an alternating magnetic field kill HER-2 positive human breast cells in vitro via hyperthermia. Int. J. Hyperthermia 2011, 27: 682-697.
56. Ito A, Kuga Y, Honda H, et al. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Letters 2004, 212: 167-175.
57. Alphandéry E, Faure S, Seksek O, et al. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano 2011, 5: 6279-6296.
58. Alphandéry E, Chebbi I, Guyot F, et al. Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review. Int. J. Hyperthermia 2013, DOI: 10.3109/02656736.2013.821527.
59. Alphandéry E. Applications of magnetosomes synthesized by magnetotactic bacteria in medicine. Frontiers in Bioengineering and biotechnology 2014, DOI: 10.3389/fbioe.2014.00005.
60. Alphandéry E, Guyot F, Chebbi I. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia. Int. J. Pharmaceutics 2012, 434: 444-452.
61. Alphandéry E, Amor M, Guyot F, et al. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties. Appl. Microbiol. Biotechnol 2012, 96: 663-670.
62. Alphandéry E, Faure S, Raison L, et al. Heat production by bacterial magnetosomes exposed to an oscillating magnetic field. J. Phys. Chem. C 2011, 115: 18-22.
63. Alphandéry E, Carvallo C, Menguy N, et al. Chains of cobalt doped magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. J. Phys. Chem. C 2011, 115: 11920-11924.
64. Alphandéry E, Lijeour L, Lalatonne Y, Motte L, et al. Different signatures between chemically and biologically synthesized nanoparticles in a magnetic sensor: A new technology for multiparametric detection. Sensors and Actuators B 2010, 147: 786-790.
65. Bazylinski DA, Frankel RB. Magnetosome formation in prokaryotes. Nature Reviews Microbiology 2004, 2: 217-230.
66. Stang J, Haynes M, Carson P, Moghaddam M. A preclinical system prototype for focused microwave thermal therapy of the breast. IEEE Trans Biomed. Eng. 2012, 59: 2431-2438.
67. Santoro G, Avossa M, Della Corte M. Radiofrequency thermoablation in locally advanced breast cancer. Breast 2012, 4: 601-6013.
68. Garbay J-R, Mathieu M-C, Lamuraglia M, Lassau N, Balleyguier C, Rouzier R. Radiofrequency Therma Ablation of Breast Cancer Local Recurrence: A Phase II Clinical Trial. Annals of Surgical Oncology 2008, 15: 3222-3226.
69. Udagawa Y, Nagasawa H, Kiyokawa S. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice. Anticancer research 1999, 19: 4125-4130.
70. Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdominal Imaging 2005, 30: 381-400.
71. Ryan T P, Turner P F, Hamilton B, Interstitial microwave transition from hyperthermia to ablation: Historical perspectives and current trends in thermal therapy. Int. J. Hyperthermia 2010, 26: 415-433.
72. Kennedy J E, Haar G R, Cranston D. High intensity focused ultrasound: surgery of the future? British Journal of Radiology 2003, 76: 590-599.
73. Mack M G, Straub R, Eichler K, Sollner O, Lehnert T, Vogl T J. Breast Cancer Metastases in Liver: Laser-induced Intersitial Thermotherapy-Local Tumor Control Rate and Survival Data. Radiology 2004, 233: 400-409.
74. Muralidharan V, Nikfarjam M, Malcontenti-Wilson C, Christophi C. Interstitial Laser Hyperthermia and the Biological Characteristics of Tumor: Study of Murine Model of Colorectal liver metastases. Journal of Clinical Laser Medicine and Surgery 2003, 21: 75-83.
75. Schena E, Saccomandi P, Giurazza F, Caponero M A, Mortato L, Di Matteo FM, Del Vescovo R, Beomonte Z B, Silvestri S. Experimental assessment of CT-based thermometry during laser ablation of porcine pancreas. Phys. Med. Biol. 2013, 58: 5705-5716.
76. Saccomandi P, Schena E, Silvestri S. Techniques for temperature monitoring during laser-induced thermotherapy: an overview. Int. J. Hyperthermia 2013, 29: 609-619.
77. Bruners P, Levit E, Penzkofer T, Isfort P, Ocklenburg C, Schmidt B, Schmitz-Rode T, Günther RW, Mahnken AH. Multi-slice computed tomography: A tool for non-invasive temperature measurement? Int. J. Hyperthermia 2010, 26: 359-365.
78. [Internet] Webpage. http: //www.nanotech-energy.net/attachments/File/06-68.pdf.